| RS1949425904 |
GRIN2B
|
Health Risk |
Likely pathogenic |
Complex neurodevelopmental disorder, Intellectual disability |
| RS1949426932 |
GRIN2B
|
Health Risk |
Pathogenic |
7 conditions, 7 conditions |
| RS1949427787 |
GRIN2B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS1949430414 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1949430616 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1949430890 |
RB1
|
Health Risk |
Likely pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1949432057 |
RB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1949433098 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1949433250 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1949433358 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1949455055 |
POMT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1949470660 |
PIK3C2G
|
Health Risk |
Likely pathogenic |
Esophageal atresia/tracheoesophageal fistula, Esophageal atresia/tracheoesophageal fistula |
| RS1949475355 |
POMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 |
| RS1949484214 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Retinoblastoma |
| RS1949484627 |
RB1
|
Health Risk |
Likely pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1949500525 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1O, Cardiovascular phenotype |
| RS1949504456 |
CD27
|
Health Risk |
Pathogenic/Likely pathogenic |
Lymphoproliferative syndrome 2, Lymphoproliferative syndrome 2 |
| RS1949506548 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1949510530 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Inborn genetic diseases |
| RS1949512290 |
PAK1
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with macrocephaly, seizures |
| RS1949512456 |
CLPB
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria, type VIIB |
| RS1949519149 |
PAK1
|
Health Risk |
Pathogenic |
PAK1-related neurodevelopmental disorders, PAK1-related disorder |
| RS1949626483 |
POMT1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1949650831 |
NADSYN1
|
Health Risk |
Pathogenic |
Vertebral, cardiac |
| RS1949678319 |
LRP6
|
Health Risk |
Pathogenic |
— |
| RS1949691247 |
FGD4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1949708829 |
MPZL2
|
Health Risk |
Likely pathogenic |
Hearing loss, autosomal recessive 111 |
| RS1949709115 |
SBF2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1949714664 |
IQCB1
|
Health Risk |
Likely pathogenic |
Senior-Loken syndrome 5, Senior-Loken syndrome 5 |
| RS1949715312 |
IQCB1
|
Health Risk |
Likely pathogenic |
Senior-Loken syndrome 5, Senior-Loken syndrome 5 |
| RS1949865586 |
NHEJ1
|
Health Risk |
Pathogenic |
Cernunnos-XLF deficiency, Cernunnos-XLF deficiency |
| RS1949866551 |
WBP11
|
Health Risk |
Pathogenic |
WBP11 spliceosomopathy, Vertebral |
| RS1949868116 |
WBP11
|
Health Risk |
Likely pathogenic |
WBP11 spliceosomopathy, Vertebral |
| RS1949868667 |
NHEJ1
|
Health Risk |
Likely pathogenic |
Cernunnos-XLF deficiency, Cernunnos-XLF deficiency |
| RS1949874222 |
POMT1
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Walker-Warburg congenital muscular dystrophy |
| RS1949874442 |
WBP11
|
Health Risk |
Pathogenic |
WBP11 spliceosomopathy, WBP11 spliceosomopathy |
| RS1949876445 |
NHEJ1
|
Health Risk |
Pathogenic |
Cernunnos-XLF deficiency, Cernunnos-XLF deficiency |
| RS1949876985 |
NHEJ1
|
Health Risk |
Pathogenic |
Cernunnos-XLF deficiency, Cernunnos-XLF deficiency |
| RS1949898946 |
POMT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 |
| RS1949900423 |
WBP11
|
Health Risk |
Likely pathogenic |
Vertebral, cardiac |
| RS1949904868 |
CBL
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1949905314 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, CBL-related disorder |
| RS1949907918 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, RASopathy |
| RS1949924324 |
EHMT1
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1949924892 |
EHMT1;LOC130003148
|
Health Risk |
Pathogenic |
— |
| RS1949929359 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS1949937601 |
SUCLA2
|
Health Risk |
Likely pathogenic |
— |
| RS1949945068 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1949946887 |
KMT2A
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1949950865 |
KMT2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1949951589 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1949951871 |
KMT2A
|
Health Risk |
Likely pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1949951988 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1949956477 |
KMT2A
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1949960915 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1949967549 |
KMT2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1949969239 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile myelomonocytic leukemia, Cardiovascular phenotype |
| RS1949969576 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1949970237 |
KMT2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1949974650 |
PFKM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type VII |
| RS1949975069 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1949980614 |
KMT2A
|
Health Risk |
Likely pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1949984032 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1949984655 |
KMT2A
|
Health Risk |
Pathogenic |
Microcephaly, Microcephaly |
| RS1949996840 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS1950023882 |
LRP6
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS1950043713 |
MPDZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Hydrocephalus, nonsyndromic |
| RS1950067375 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome and Noonan-related syndrome, RASopathy |
| RS1950068369 |
GRIN2B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS1950068661 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1950069134 |
KMT2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1950069464 |
GRIN2B
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1950069601 |
GRIN2B
|
Health Risk |
Likely pathogenic |
— |
| RS1950071002 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1950071303 |
KMT2A
|
Health Risk |
Likely pathogenic |
— |
| RS1950080058 |
ZMYND11
|
Health Risk |
Pathogenic |
— |
| RS1950106219 |
KMT2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1950106455 |
KMT2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1950124035 |
SUCLA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria |
| RS1950137753 |
KMT2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1950141561 |
KMT2A
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1950141836 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1950143446 |
KMT2A
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1950196208 |
SUCLA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria |
| RS1950203796 |
KMT2A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1950250678 |
YAP1
|
Health Risk |
Likely pathogenic |
Uveal coloboma-cleft lip and palate-intellectual disability, Uveal coloboma-cleft lip and palate-intellectual disability |
| RS1950265792 |
POMT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 |
| RS1950284130 |
POMT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 |
| RS1950371099 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1950378051 |
KMT2A
|
Health Risk |
Likely pathogenic |
Rubinstein Taybi like syndrome, Rubinstein Taybi like syndrome |
| RS1950408951 |
KMT2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1950436398 |
KMT2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1950444447 |
KMT2A
|
Health Risk |
Likely pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1950445312 |
KMT2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Wiedemann-Steiner syndrome |
| RS1950456995 |
CAPN5
|
Health Risk |
Pathogenic |
Proliferative vitreoretinopathy, Proliferative vitreoretinopathy |
| RS1950474024 |
C1QTNF5
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1950502854 |
KMT2A
|
Health Risk |
Likely pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1950507886 |
PAX6
|
Health Risk |
Pathogenic |
Irido-corneo-trabecular dysgenesis, Aniridia 1 |
| RS1950517316 |
MFRP
|
Health Risk |
Pathogenic |
Isolated microphthalmia 5, Isolated microphthalmia 5 |
| RS1950519775 |
KMT2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |